View Item 

Show simple item record

Successful Immunization of an Allogeneic Bone Marrow Transplant Recipient with Live, Attenuated Yellow Fever Vaccine

dc.contributor.authorYax, Justin A.en_US
dc.contributor.authorFarnon, Eileen C.en_US
dc.contributor.authorCary Engleberg, N.en_US
dc.date.accessioned2010-06-01T22:23:21Z
dc.date.available2010-06-01T22:23:21Z
dc.date.issued2009-09en_US
dc.identifier.citationYax, Justin A.; Farnon, Eileen C.; Cary Engleberg, N. (2009). "Successful Immunization of an Allogeneic Bone Marrow Transplant Recipient with Live, Attenuated Yellow Fever Vaccine." Journal of Travel Medicine 16(5): 365-367. <http://hdl.handle.net/2027.42/75383>en_US
dc.identifier.issn1195-1982en_US
dc.identifier.issn1708-8305en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75383
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19796110&dopt=citationen_US
dc.format.extent633367 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2009 International Society of Travel Medicineen_US
dc.titleSuccessful Immunization of an Allogeneic Bone Marrow Transplant Recipient with Live, Attenuated Yellow Fever Vaccineen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherArboviral Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USAen_US
dc.contributor.affiliationotherPresent address: Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAen_US
dc.identifier.pmid19796110en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75383/1/j.1708-8305.2009.00336.x.pdf
dc.identifier.doi10.1111/j.1708-8305.2009.00336.xen_US
dc.identifier.sourceJournal of Travel Medicineen_US
dc.identifier.citedreference1. Centers for Disease Control and Prevention. Health information for international travel 2008. Atlanta: US Department of Health and Human Services, Public Health Service, 2007.en_US
dc.identifier.citedreference2. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000; 49 ( RR-10 ): 99.en_US
dc.identifier.citedreference3. Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveler. Can Commun Dis Rep 2007; 33 ( ACS-4 ): 1 – 24.en_US
dc.identifier.citedreferenceLjungman P, Engelhard D, de la Camara R, et al. for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737 – 746.en_US
dc.identifier.citedreferenceSinghal S, Mehta J. Reimmunization after blood or marrow stem cell transplantation. Bone Marrow Transplant 1999; 23: 637 – 646.en_US
dc.identifier.citedreferenceKotton CN, Ryan ET, Fishman JA. Prevention of infection in adult traveler after solid organ transplantation. Am J Transplant 2005; 5: 8 – 14.en_US
dc.identifier.citedreferenceGowda R, Cartwright K, Bremner JAG, et al. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004; 72: 299 – 301.en_US
dc.identifier.citedreferenceReceveur MC, Thiebaut R, Vedy S, et al. Yellow fever vaccination of human immunodeficiency virus infected patients: report of two cases. Clin Infect Dis 2000; 31: e7 – e8.en_US
dc.identifier.citedreferenceKengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002; 85: 131 – 134.en_US
dc.identifier.citedreferenceMonath TP. Yellow fever vaccine. In: Plotkin S, Orenstien W, eds. Vaccines. 4th ed. Phila: WB Saunders, 2003; 1095 – 176.en_US
dc.identifier.citedreferenceBarwick RE. History of thymoma and yellow fever vaccination. Lancet 2004; 364: 936.en_US
dc.identifier.citedreferenceVasconcelos PFC, Luna EJ, Galler R, et al. Brazilian Yellow Fever Vaccine Evaluation Group. Serious adverse events associated with yellow fever 17D vaccine in Brazil: report of two cases. Lancet 2001; 358: 91 – 97.en_US
dc.identifier.citedreferenceMartins RM, Galler R, Freire MS, et al. Letter to the editor: yellow fever vaccination: some thoughts on how much is enough. Vaccine 2007; 25: 10 – 11.en_US
dc.identifier.citedreferenceMassad E, Coutinho FAB, Burattini MN, et al. Yellow fever vaccination: how much is enough? Vaccine 2005; 23: 3908 – 3914.en_US
dc.identifier.citedreferenceKhromava AY, Eidex RB, Weld LH, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 2005; 23: 3256 – 3263.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1708-8305.2009.00336.x.pdf
Size:
618.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.